 PET is literally a molecular imaging modality. In monitoring the patients response to a specific chemotherapeutic regime, baseline and subsequent PETCT scans can be used to quantitatively determine the therapeutic effect of the regime, using the standard uptake value SUV, a common metric in PET imaging. The breast PETCT system will facilitate molecular imaging of breast cancer using a number of radiolabeled molecules, available both commercially 18-FDG and from the research environment. 